Position in MNKD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,330,615
+$716,133 QoQ
Shares Held
312,351
+24.5% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 254 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. MNKD ranks #51 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in MNKD
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,330,615 | 312,351 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $614,482 | 250,809 | Shares | Defined | 2026-05-08 | |
| 2025-09-30 | $821,513 | 152,982 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $613,195 | 163,956 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,106,418 | 219,964 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,433,877 | 222,998 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,310,401 | 208,331 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,108,921 | 212,437 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $864,043 | 190,738 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $666,047 | 182,980 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $818,111 | 198,090 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $790,711 | 194,278 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $710,956 | 173,404 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $940,231 | 178,412 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $434,169 | 140,508 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $570,814 | 149,820 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $952,336 | 258,787 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,270,726 | 290,784 | Shares | Defined | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||